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SUMMARY
The cellular and molecular mechanisms mediating histamine-independent itch in primary sensory
neurons are largely unknown. Itch induced by chloroquine (CQ) is a common side-effect of this
widely used anti-malarial drug. Here we show that Mrgprs, a family of G protein-coupled receptors
expressed exclusively in peripheral sensory neurons, function as itch receptors. Mice lacking a cluster
of Mrgpr genes display significant deficits in itch induced by CQ but not histamine. CQ directly
excites sensory neurons in an Mrgpr-dependent manner. CQ specifically activates mouse MrgprA3
and human MrgprX1. Loss- and gain-of-function studies demonstrate that MrgprA3 is required for
CQ responsiveness in mice. Furthermore, MrgprA3-expressing neurons respond to histamine and
co-express Gastrin-Releasing Peptide, a peptide involved in itch sensation, and MrgprC11.
Activation of these neurons with MrgprC11-specific agonist BAM8-22 induces itch in wild-type but
not mutant mice. Therefore, Mrgprs may provide molecular access to itch-selective neurons and
constitute novel targets for itch therapeutics.
INTRODUCTION
Itch, formally known as pruritus, has been defined as an “unpleasant skin sensation that elicits
the desire or reflex to scratch” (Ikoma et al., 2006). Primary sensory neurons in dorsal root
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ganglia (DRG) play an essential role in generating itch by detecting pruritogenic stimuli
through their peripheral axons in the skin and mucosal surfaces and sending the signals to the
spinal cord via their central axons (Paus et al., 2006). The best characterized itch mediator is
histamine, which is mainly secreted by skin mast cells and excites nearby sensory fibers by
acting on histamine receptors (Alving et al., 1991). Histamine-induced itch in human can be
almost completely blocked by histamine receptor H1 antagonists. However, the blockers are
ineffective in many other itch conditions, such as those arising from atopic dermatitis, renal
and liver diseases, the side effects of drugs, plant toxins and mechanical stimuli (Paus et al.,
2006). These observations, together with other electrophysiological and molecular studies,
strongly imply the existence of histamine-independent types of itch (Davidson et al., 2007;
Johanek et al., 2007; Johanek et al., 2008). A major hurdle to investigating histamine-
independent itch is the lack of information about the receptors directly activated by non-
histaminergic pruritogens as well as molecular markers for itch-sensing neurons in the DRG.
Chloroquine (CQ) is a drug which has long been used in the treatment and prevention of
malaria. One major side effect of this drug is itch, which is very common among black Africans
(up to 70%), but less common in other races. Pruritus is a major cause of non-compliance in
the treatment of malaria as ~30% of African patients refused further CQ treatment because of
unbearable itch (Mnyika and Kihamia, 1991; Sowunmi et al., 2000). This non-compliance may
lead to the development and spread of CQ-resistant Plasmodium falciparum. CQ-induced itch
is not considered an allergic reaction since pruritus is seen after first exposure (Ademowo,
1998; Olatunde, 1977). More importantly, it cannot be treated effectively by anti-histamine
drugs suggesting a histamine-independent pathway is involved (Abila et al., 1994; Ezeamuzie
et al., 1990). CQ-induced itch is also well documented in mouse. Subcutaneous CQ injection
in wild- type (WT) mice acutely evokes a pronounced scratching behavior (Green et al.,
2006). Interestingly, mice lacking gastrin-releasing peptide receptor (GRPR), which is
specifically expressed in dorsal horn neurons of the spinal cord, exhibit severely reductions in
itch responses evoked by various pruritogens including CQ (Sun and Chen, 2007).
Furthermore, mice with GRPR-expressing dorsal horn neurons selectively ablated showed
profound scratching deficits whereas pain behaviors were unaffected in these animals (Sun et
al., 2009). These findings suggest that both GRPR and the second-order neurons in the spinal
cord marked by GRPR are important for transmitting itch signals from primary sensory
afferents. However, it is unknown whether CQ directly activates primary sensory fibers in the
skin and if cell surface receptors are involved in the process.
Several G protein-coupled receptors (GPCRs) have been shown to be essential in generating
itch including histamine receptors and protease activated receptors (PARs) (Shim and Oh,
2008; Steinhoff et al., 2003). Mrgprs (also named Mrg/SNSR) are a family of orphan GPCRs
consisting of more than 50 members in the mouse genome that can be grouped into several
subfamilies: MrgprA1-22, MrgprB1-13, MrgprC1-14, and MrgprD-G (Dong et al., 2001;
Zylka et al., 2003). Strikingly, the expression of Mrgprs, including MrgprAs, MrgprB4,
MrgprB5, MrgprC11 and MrgprD, is restricted to subsets of small-diameter sensory neurons
in DRG and trigeminal ganglia, and has not been detected in the central nervous system or in
the rest of the body (Dong et al., 2001; Zylka et al., 2003). Similarly, human MrgprXs are also
selectively expressed in DRG neurons (Lembo et al., 2002).
Mrgprs can be activated by peptides terminating in RF/Y-G or RF/Y-amide such as molluscan
FMRFamide and mammalian neuropeptide FF (NPFF), neuropeptide AF (NPAF), γ2-
melanocyte-stimulating hormone (γ2-MSH) and bovine adrenal medulla peptide (BAM).
These peptides can activate heterologously expressed mouse MrgprA1, MrgprA4, MrgprC11,
and human MrgprX1 with different sensitivities (Dong et al., 2001; Han et al., 2002; Lembo
et al., 2002). The highly restricted expression of these receptors suggests that Mrgprs are likely
involved in somatosensation including pain or itch, but direct evidence for this is lacking. Here
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we demonstrate that certain Mrgprs function as receptors for CQ and mediate its direct
activation of a small subset of DRG neurons and CQ-induced itch. More importantly, CQ-
sensitive neurons, comprising only 4–5% of total DRG neurons, may define a subpopulation
of DRG neurons that mediate itch.
RESULTS
Targeted deletion of a cluster of Mrgpr genes
Many Mrgpr genes are clustered together on mouse chromosome 7 (Dong et al., 2001; Zylka
et al., 2003). To determine the function of Mrgprs in vivo while overcoming the potential
problem of gene redundancy, we generated a mouse line in which a cluster of Mrgpr genes
was deleted (Figure 1A and 1B). The deleted 845-kilobase region comprises ~30 Mrgpr genes,
twelve of which (MrgprA1-4, A10, A12, A14, A16, A19, B4, B5 and C11) have intact open
reading frames (ORFs, Figure 1A). No other ORF is present in this region according to the
Mouse Genome Project. Although the mouse Mrgpr superfamily consists of over 50 members,
more than half are pseudogenes and only ~24 genes have intact ORFs (Dong et al., 2001; Han
et al., 2002). Therefore, the deleted cluster represents ~50% of the potentially functional
Mrgpr repertoire and contains most MrgprA and MrgprC genes as well as some members of
the MrgprB subfamily. The deleted Mrgpr genes are specifically expressed in DRG (Dong et
al., 2001; Han et al., 2002; Zylka et al., 2003). MrgprA6, A9, A11, B1, B2, B6, B8, B10, and
D-G are not included in this deletion based on the Mouse Genome Project and RT-PCR
experiments (data not shown). Notably, MrgprB1 and MrgprB2, which were not deleted, are
expressed in the skin but not in DRG (Zylka et al., 2003).
Mating between mice heterozygous for the cluster deletion (Mrgpr-clusterΔ−/+) produced
offspring with the expected Mendelian distribution of gender and genotype. Homozygous
Mrgpr-clusterΔ−/− mice are viable, fertile and generally indistinguishable from WT littermates
in appearance, body weight, overt behavior and gross anatomy. The motor function of Mrgpr-
clusterΔ−/− mice is also normal as determined by the rotarod test (data not shown).
Furthermore, Mrgprs are not required for neuronal survival, fate determination or
differentiation of small-diameter sensory neurons (Figure 1C; Supplemental Data).
Mrgpr-clusterΔ−/− mice exhibit severe reduction in CQ-induced scratching
Activation of small-diameter sensory neurons in DRG can generate different types of
somatosensation including pain and itch with specific and distinct behavioral responses. For
instance, pain and itch cause withdrawal and scratching responses, respectively (Ikoma et al.,
2006). We next investigated whether the deletion of Mrgpr genes affects behavioral responses
to pain- and itch-inducing stimuli. Mrgpr-clusterΔ−/− mice responded normally to acute
noxious heat, cold, mechanical and chemical stimulation as compared with WT littermates
(Figure 2A–2F). Thus, acute pain sensation appears unaffected in Mrgpr-clusterΔ−/− mice. In
addition, Mrgpr mutant mice exhibited modest but statistically significant increases only at
certain testing time points in inflammatory hyperalgesia induced by complete Freund’s
adjuvant (CFA) or carrageenen injection. No significant difference was found in neuropathic
pain caused by L5 spinal nerve ligation between mutant and wild-type mice (Figure S1).
In addition to pain, we evaluated chemically induced itch responses in Mrgpr-clusterΔ−/− mice.
No significant difference was found between Mrgpr-clusterΔ−/− and WT mice in the total
number of scratching bouts induced by histamine over a period of 30 min (Figure 2G).
Consistent with this result, WT and mutant mice also showed similar responses to compound
48/80, a drug that elicits mast cell degranulation and induces histamine-dependent itch
(Kuraishi et al., 1995; Nakayama et al., 2002) (Figure 2H). These results suggest that Mrgprs
are not involved in histamine-dependent itch.
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Strikingly, itch induced by CQ was strongly reduced in Mrgpr-clusterΔ−/− mice. Figure 2I
shows the time course of scratching bouts at 5 min intervals after CQ injection. Typically, the
first bout was observed within 1 to 2 min after injection, and scratching peaked within 15 min
in WT mice. In contrast, Mrgpr-clusterΔ−/− mice showed a delayed occurrence of the first
scratching behavior (WT 57.8 ± 25.4 sec versus KO 280.5 ± 35.0 sec; P=0.0004). The total
number of scratching bouts induced by CQ were 278 ± 21 in WT mice and 104 ± 13 in Mrgpr-
clusterΔ−/− mice (Figure 2I). Interestingly, injection of a CQ precursor, quinoline, did not
evoke any scratching behavior (see below for quinoline’s structure and inability of activating
Mrgprs) in both WT and mutant mice (Figure 2J). However, immediately after quinoline
treatment, CQ injection at the same location induced robust scratching behavior in WT mice;
and the number of scratches induced by this treatment was again severely reduced in Mrgpr-
clusterΔ−/− mice (Figure 2J). These results suggest that CQ-induced itch, but not histaminergic
itch, is affected in the cluster deletion mice. Similarly, intradermal injection of CQ in rats
evoked profound scratching responses whereas quinoline did not (Figure S2A). These data
provide further evidence that CQ-evoked itch is well-conserved.
Previous studies have indicated that CQ can cause mast cell degranulation (Green and Lim,
1989; Nosal et al., 1991). To determine if this effect on mast cells contributes to CQ-evoked
scratching behavior, we repeated the experiment on SASH mice, which lack mast cells due to
a chromosomal inversion in the regulatory element of the Kit gene (Yamazaki et al., 1994). As
compared to WT controls, SASH mice exhibited a modest but significant reduction in CQ-
induced scratching behavior (Figure 2K). The mast cell deficiency in these mice was confirmed
by a dramatic decrease in the level of histamine released upon skin mast cell degranulation
(Figure 2L). These results confirm that degranulation of mast cells induced by CQ contributes
to scratching behavior, which may account for the residual response to CQ in Mrgpr-
clusterΔ−/− mice.
CQ directly excites DRG neurons in an Mrgpr-dependent manner
Since CQ-induced itch is not considered an allergic reaction, we hypothesized given our results
that this type of itch results from a direct activation of DRG neurons by the drug. If so, then
the behavioral deficit seen in mutant mice would be attributed to a loss of CQ responsiveness
in primary sensory neurons. Indeed, 1 mM CQ treatment of cultured DRG neurons evoked a
robust intracellular calcium ([Ca2+]i) increase in ~4–5% of the cells from WT mice. In contrast,
none of the neurons in cultures derived from Mrgpr-deficient mice exhibited any significant
response to CQ (Figure 3B). These data indicate that the CQ-evoked [Ca2+]i increases seen in
WT DRG cultures reflect specific activation of a subset of cells, and that this activation is
Mrgpr-dependent. In contrast, the percentage of DRG neurons responding to histamine was
identical between WT and mutant cultures, consistent with the behavioral data and providing
further evidence that histamine-induced itch is unaffected in Mrgpr-clusterΔ−/− mice (Figure
3A).
We performed additional experiments to further characterize [Ca2+]i increases in WT neurons.
Sequential application of CQ caused a ~20% reduction of calcium responses. In addition,
extracellular Ca2+ was necessary for the CQ-induced increase in [Ca2+]i since the CQ effect
was almost completely blocked in Ca2+-free bath solution. Ruthenium red, an inhibitor of
several TRP channels (Fujita et al., 2007), also severely attenuated the effect, indicating that
TRPs are likely involved in the CQ signaling pathway (Figure 3C and D). Signaling via TRP
channels has been observed for many GPCRs in DRG neurons including the histamine and
bradykinin receptors (Chuang et al., 2001; Shim et al., 2007).
We also examined whether CQ can directly induce action potentials (APs) in dissociated DRG
neurons, using whole-cell patch clamp recording. In WT DRG, all CQ-sensitive neurons
(identified by calcium imaging) displayed a train of APs upon subsequent CQ treatment (Figure
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3E). In contrast, all neurons that fail to show a calcium response to CQ also failed to generate
APs with a similar treatment (n=5). As in the calcium imaging experiments, none of 11 size-
matched neurons (diameter: ~20 µm) tested from Mrgpr-clusterΔ−/− mice showed any
response to the drug. These studies provide strong evidence that CQ can directly excite a small
subpopulation of sensory neurons in DRG and that Mrgprs are required for this effect. Similar
to the mouse results, CQ induces robust activation in a subset of rat DRG neurons as determined
by both an increase in [Ca2+]i and generation of APs (Figure S2).
CQ specifically activates mouse MrgprA3 and human MrgprX1
The Mrgpr-clusterΔ−/− behavioral and cellular loss-of-function phenotypes strongly suggest
that Mrgprs function as cell surface receptors for CQ. To test this possibility directly, we
examined whether Mrgprs have the ability to confer sensitivity to CQ on heterologous cells.
We cloned each of the twelve Mrgprs that were deleted in Mrgpr-clusterΔ−/− mice (Figure
1A) into a mammalian expression vector, and transfected them individually into human
embryonic kidney (HEK) 293 cells. By fusing green fluorescent protein (GFP) to the C-termini
of the Mrgpr coding sequences, we were able to visualize both transfected cells and the proper
membrane localization of the receptors. Our previous studies demonstrated that GFP does not
disturb the normal function of Mrgprs (Dong et al., 2001; Han et al., 2002). Increased
[Ca2+]i resulting from activation of the receptors was monitored by calcium imaging. Among
the twelve mouse Mrgprs, only MrgprA3 conferred a strong response to CQ on HEK cells,
whereas the other receptors conferred either weak or no responses to the drug (Figure 4A–D,
Figure 5B, data not shown). MrgprA1, MrgprA4, and MrgprC11 were activated by their peptide
agonists FMRF, NPFF, and BAM8-22, respectively, confirming they are functional receptors
but insensitive to CQ (Figure 4A, C and D). Furthermore, MrgprA3-expressing HEK cells did
not respond to BAM8-22 or histamine, indicating that MrgprA3 is a specific receptor for CQ
(Figure 4B). Conversely, histamine receptor H1-expressing HEK293 cells failed to show any
response to CQ (Figure 4F).
The human Mrgpr family (i.e. MrgprXs) is much smaller than the murine family. Although
the human and mouse genes share strong sequence homology, they do not form clear
orthologous pairs. We found that MrgprX1-expressing HEK293 cells responded to CQ whereas
MrgprX2- and X3-expressing cells were completely insensitive to the drug (Figure 4E, data
not shown). Together these data suggest that CQ directly activates mouse MrgprA3 and human
MrgprX1 in heterologous cells with high specificity.
In order to determine the lowest concentrations of CQ capable of activating MrgprA3 and X1,
we performed dose-response experiments in HEK293 cells. These experiments indicated that
the receptors could be activated by the drug at micromolar concentrations with the mouse
receptor showing 10-fold higher sensitivity than the human receptor (Figure 5B and D).
EC50s for MrgprA3 and MrgprX1 are 27.55 ± 2.03 and 297.68 ±2.10 µM, respectively (see
Discussion regarding the low potency of CQ on MrgprX1). Besides CQ, we also determined
the sensitivities of these receptors to other structurally related compounds (i.e. quinoline,
quinine and serotonin) (Figure 5A). Quinoline is used as an intermediate in the production of
various compounds including CQ. Despite the presence of a bicyclic structure, quinoline
completely failed to activate MrgprA3 and MrgprX1 suggesting that the side chain in CQ is
also necessary for activation (Figure 5B and D). Consistently, quinoline does not induce any
scratching behavior in mice (Figure 2J). Serotonin also has a bicyclic structure. But unlike CQ
or quinoline, its bicyclic structure consists of a six-membered benzene ring fused to a five-
membered nitrogen-containing pyrrole ring (Figure 5A). Serotonin failed to activate MrgprA3
at a concentration of 100 µM (Figure 5B). Quinine is another drug used to treat malaria and
its side effects also include itch. However, it is unclear if quinine-induced itch is an allergic
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response (Gonzalez et al., 2002; Kanny et al., 2003). Unlike CQ, quinine weakly activates
MrgprA3 (Figure 5B).
MrgprA3 is the major receptor mediating CQ responsiveness in DRG neurons
We and other groups have shown that MrgprA3 is expressed in a small subset (i.e. 4–5%) of
WT DRG neurons (Dong et al., 2001; Liu et al., 2008; Zylka et al., 2003). The population of
MrgprA3+ neurons is small in comparison to that expressing another Mrgpr member, MrgprD
(Figure 6A). According to our previous studies, MrgprA3 has the highest expression level
among all MrgprAs in adult mouse DRG whereas MrgprA1 is dramatically down-regulated to
expression in few neurons, all of which are also MrgprA3+ (Zylka et al., 2003). To confirm
the expression profile of MrgprA3, we performed RT-PCR on various adult mouse tissues.
Among the tissues tested, MrgprA3 is found exclusively in DRG and nodose ganglia (Figure
6B). The low intensity of the MrgprA3 band as compared to that of GAPDH is consistent with
the fact that only a small percentage of neurons express MrgprA3 in these ganglia. Human
MrgprX1 exhibits a similar expression pattern (Lembo et al., 2002). This result also suggests
that mast cells are unlikely to express MrgprA3. We did not see MrgprA3 in the skin, which
contains many mast cells, nor did we see MrgprA3 expression in primary mast cells enriched
from skin (Figure 6B) or bone marrow- derived mast cells (data not shown). Therefore, the
transmission of CQ-induced itch signal by MrgprA3 likely occurs in primary sensory neurons
in DRG and not other cell types in the skin.
To determine whether the expression of MrgprA3 in DRG neurons correlates with CQ
sensitivity (also 4–5%), we performed single cell RT-PCR for the gene on individual DRG
neurons responsive to CQ as determined by calcium imaging. 8 of 9 CQ-responding neurons
expressed MrgprA3 mRNA whereas none of 11 CQ-insensitive neurons showed detectable
levels of the receptor transcript (Figure 6C). Since MrgprA3 expression in mouse DRG neurons
correlates very well with CQ sensitivity, we examined whether specific knock-down of
MrgprA3 would abolish CQ responsiveness. Strikingly, WT DRG neurons failed to respond
CQ after electroporation with siRNA specifically targeted against MrgprA3, whereas a control
siRNA had no effect on CQ sensitivity (Figure 6D–F). These data strongly suggest that
MrgprA3 is the main receptor mediating CQ-evoked responses in mice. Unlike mouse MrgprA
subfamily which consists of 22 members, rats have only one MrgprA. Consistently, using single
neuron RT-PCR technique, we found that all of CQ-sensitive rat DRG neurons express rat
MrgprA (n=10).
MrgprA3 and MrgprX1 rescue the phenotypes of Mrgpr-deficient neurons
We next asked whether MrgprA3 or MrgprX1 can rescue the phenotypes of DRG neurons from
Mrgpr-clusterΔ−/− mice. To answer this question, we electroporated the Mrgpr expression
constructs used in the heterologous studies into dissociated adult DRG neurons from these
mice. After 24 hour in culture, expression and membrane localization of the transfected Mrgprs
in the mutant neurons could be readily visualized by GFP (Figure 6G). Strikingly, all MrgprA3-
expressing mutant neurons generated numerous APs in response to CQ treatment (Figure 6H)
whereas neighboring GFP-negative neurons remained silent (n=6, not shown). The number of
APs generated in the GFP-positive neurons was comparable to that produced by CQ treatment
of WT DRG neurons, indicating a nearly complete rescue by MrgprA3. Similar results were
obtained for Mrgpr-deficient neurons electroporated with MrgprX1 (Figure 6J). In contrast,
fewer than half of the MrgprA1-electroporated neurons elicited a few APs in response to CQ
(Figure 6I). Rescue by MrgprA3 and MrgprX1 was also seen using calcium imaging, with an
increase in [Ca2+]i induced by CQ (Figure 6K–M). Together these results strongly suggest that
mouse MrgprA3 and human MrgprX1 are the major CQ receptors in DRG neurons. Expression
of rat MrgprA in Mrgpr-clusterΔ−/− DRG neurons conferred CQ sensitivity upon them whereas
rat MrgprC did not (Figure S2D, E).
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CQ-sensitive neurons also respond to histamine and capsaicin
To further define the population of CQ-sensitive neurons in DRG, we examined the responses
of these cells to other well-characterized chemicals. Many studies utilizing multiple approaches
have shown that histamine- and capsaicin-responding cells largely overlap (Schmelz et al.,
2003; Shim et al., 2007). Consistent with previous reports, we found that 87% of histamine-
sensitive DRG neurons also responded to capsaicin as monitored by an increase in [Ca2+]i
using calcium imaging. Interestingly, all CQ-responding neurons in DRG cultures were also
activated by both histamine and capsaicin (Figure 7A). Furthermore, we noticed that CQ-
sensitive cells have a narrow range of cell diameters whereas histamine-sensitive neurons have
a wide range (Figure S3). Therefore, the small population of CQ-sensitive neurons in WT DRG
defines a unique and specific subset of histamine- and capsaicin-sensitive neurons.
MrgprA3-expressing neurons are likely itch-selective neurons
The finding that MrgprA3-positive neurons are sensitive to both histamine and CQ raises the
interesting possibility that these neurons are itch-selective neurons. Gastrin-releasing peptide
(GRP), a ligand for GRPR, is expressed in a subset of DRG neurons (Sun and Chen, 2007).
To look for overlap between GRP and MrgprA3 expression in DRG neurons, we carried out
double staining experiments for these two genes. Strikingly, 93% of MrgprA3-positive neurons
also expressed GRP, providing strong evidence that MrgprA3-expressing neurons may play
important roles in itch sensation (Figure 7F and Figure S4).
Our previous data have shown that expression of MrgprC11 largely overlaps with that of
MrgprA3 (Zylka et al., 2003). Consistently, all BAM8-22-responsive neurons (i.e. 3.6% of
total WT DRG neurons) also responded to CQ (Figure 7C–E). Importantly, no DRG neurons
from Mrgpr-clusterΔ−/− mice responded to BAM8-22 (Figure 7C). As we expected,
intradermal injection of BAM8-22 induced strong scratching behavior in WT mice whereas
mutant mice exhibited a dramatic reduction in the response evoked by the peptide (Figure 7B).
Together these data suggest that activation of MrgprA3- or MrgprC11-expressing neurons by
its specific agonist (i.e. CQ and BAM8-22, respectively) can evoke scratching behavior and
further support that these neurons are involved in itch sensation.
DISCUSSION
It has been known for a long time that both pain and itch are initiated and modulated by small-
diameter sensory neurons in DRG (Caterina and Julius, 1999; Ikoma et al., 2006; Shim and
Oh, 2008). Compared to pain, our knowledge of itch especially histamine-independent itch at
cellular and molecular levels is poor. Here we present evidence showing that sensory neuron-
specific Mrgprs are receptors mediating CQ-induced itch.
Mrgpr-clusterΔ−/− mice exhibit a severe reduction in CQ-induced scratching behavior whereas
histamine-mediated itch and acute pain are completely normal. The residual CQ-induced
scratching behavior seen in mutant animals is likely due to an indirect effect on skin sensory
nerves. Both our behavioral data from SASH mice and complete elimination of CQ-sensitive
neurons in Mrgpr-clusterΔ−/− DRG support this notion and suggest that the residual CQ-
induced response in Mrgpr-clusterΔ−/− mice results from degranulation of skin mast cells
caused by the drug, a phenomenon observed in previous studies (Green and Lim, 1989; Nosal
et al., 1991).
Since Mrgpr members are highly homologous to each other, especially the MrgprA subfamily
(70%-80% identity), it is surprising to find that only MrgprA3 shows strong activation by CQ.
The most divergent regions of MrgprAs are localized to the extracellular loops consistent with
the differences in their ligand preferences (Dong et al., 2001; Yang et al., 2005). Bioinformatic
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analysis of Mrgpr sequences suggest that positive selection likely accounts for the amino acid
substitutions in the extracellular domains (Choi and Lahn, 2003; Yang et al., 2005).
Interestingly, human MrgprX1 can respond to both CQ and BAM8-22 while mouse MrgprA3
and MrgprC11 are specific receptors for these two agonists, respectively. The agonist
selectivity of the mouse receptors supports the conclusion made from statistical analysis that
adaptive evolution of Mrgpr family contributes to its expansion in the mouse genome.
According to our dose-response curves, EC50s of CQ for MrgprA3 and human MrgprX1 are
27.55 ± 2.03 and 297.68 ±2.10 µM, respectively. Although the concentration of CQ in patient
plasma is in the micromolar range, excretion of the drug is quite slow and it is deposited in
tissues in considerable amounts (Adam, 2004; Evans et al., 2005; Onyeji and Ogunbona,
2001). Since CQ binds strongly to melanin that is synthesized by melanocytes, it accumulates
at very high levels in the skin and other pigmented tissues to reach high micromolar to
millimolar concentrations (Dencker et al., 1975; Olatunde, 1971; Sams and Epstein, 1965;
Tanaka et al., 2004). The high level of CQ (i.e. high micromolar to millimolar concentrations)
is also required to induce scratching behavior in mice based on our and other group’s dose-
response studies (data not shown; Green et al., 2006). In addition, patients prone to CQ-induced
itch accumulate higher concentrations of CQ in their skin than those not prone to the side effect
(Olatunde, 1971). The different levels of CQ in the skin of the two groups are likely due to
different rates of metabolism of the drug (Onyeji and Ogunbona, 2001). Besides the level of
CQ in the skin, mouse strain comparison and human familial clustering of itch studies suggest
that genetic variability also contributes to phenotypic differences in CQ-induced itch (Ajayi et
al., 1989; Green et al., 2006). The high polymorphism seen in both mouse and human Mrgpr
genes may provide a molecular explanation for the variability in itch levels among different
individuals (Dong et al., 2001; Yang et al., 2005).
Our heterologous studies indicate that MrgprA3 is the major receptor for CQ among the twelve
deleted Mrgprs. Other Mrgprs excluded in the cluster deletion are unlikely involved in CQ
signaling in DRG neurons because of the total loss of CQ response in mutant DRG.
Consistently, the percentage of CQ-sensitive DRG neurons (i.e. 4–5% of total DRG neurons)
matches that of MrgprA3-expressing cells determined by in situ hybridization on adult DRG
sections (Liu et al., 2008). More importantly, our single neuron RT-PCR results indicate that
MrgprA3 expression correlates almost perfectly to CQ responsiveness. Furthermore, both gain-
and loss-of-function studies firmly establish that MrgprA3 is required for CQ responsiveness
in mice.
This small population of CQ-sensitive neurons marks a subset of histamine- and capsaicin-
responsive cells in DRG and it has a uniform cell size as compared to the total histamine-
sensitive population. According to different reports, the percentage of histamine-sensitive cells
in the DRG ranges from 15% to 40% (Han et al., 2006; Kim et al., 2004; Nicolson et al.,
2002). It is unlikely that all of these cells are pruriceptive neurons. In fact, human
microneurography studies suggest the sensory fibers that respond to histamine with sustained
discharges are responsible for itch whereas those weakly activated by histamine are involved
in pain processing (Schmelz et al., 1997). The strong histamine-responsive fibers comprise
only a small portion of all unmyelinated sensory fibers and the majority of them are heat-
responsive. Recent studies have shown that TRPV1, a molecular sensor for capsaicin and heat,
functions downstream of histamine receptors and is required for histamine-induced DRG
neuron activation and itch behavior (Shim et al., 2007). These studies also raise the interesting
possibility that a subset of capsaicin- and heat-sensitive neurons mediates itch. Therefore, it
would be important to know whether the 4–5% of total DRG neurons activated by CQ is
selective for itch. Activation of CQ-sensitive neurons by BAM8-22 through MrgprC11 also
induces scratching response, providing further evidence that CQ-sensitive neurons may be itch-
selective neurons. Finally, overlap between MrgprA3- and GRP-expressing neurons in DRG
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leads us to propose a model for CQ signal transduction: CQ directly activates a subset of
primary sensory fibers in the skin through MrgprA3. This leads to the release of GRP into the
dorsal horn of the spinal cord where it activates a subset of dorsal horn neurons through GRPR.
Therefore, the identification of Mrgprs as receptors for CQ may open new avenues for the
exploration of itch-selective neuron development and function as well as developing novel
anti-itch drugs.
EXPERIMENTAL PROCEDURES
Generation of Mrgpr-clusterΔ−/− mice
To delete a cluster of Mrgpr genes in the mouse germline, we constructed two replacement
vectors for MrgprA1 and MrgprB4, which reside on either end of the Mrgpr cluster. The entire
open reading frames (ORFs) of both MrgprA1 and MrgprB4 are encoded by a single exon. The
arms of the MrgprA1 and MrgprB4 targeting constructs were obtained by PCR amplification
from 129/SvJ genomic DNA using Expand High Fidelity PCR System (Roche). Details of the
generation of Mrgpr-clusterΔ−/− mice are available in the Supplemental Data.
Behavioral studies
All behavioral tests were performed with an experimenter blind to genotype. The mice were 2
to 3 month-old males (20–30 g) that had been backcrossed to C57Bl/6 mice for at least ten
generations. Rat studies were done using four week old CD® animals (Charles River
Laboratories). All experiments were performed under the protocol approved by the Animal
Care and Use Committee of Johns Hopkins University School of Medicine. Pruritic compounds
(i.e. histamine, compound 48/80, and CQ) were subcutaneously injected into the nape of the
neck after acclimatization and scratching behavior was observed for 30 min. A bout of
scratching was defined as continuous scratch movements with hind paws directed at the area
around the injection site. Scratching behavior was quantified by recording the number of
scratching bouts at 5 min intervals over the 30 min observation period. Details for other
behavior assays are available in the Supplemental Data.
Cultures of dissociated DRG neurons
DRG from all spinal levels of 4-week old mice or rats were collected in cold DH10 medium
and treated with enzyme solution at 37°C. Following trituration and centrifugation, cells were
resuspended in DH10, plated on glass cover slips coated with poly-D-lysine and laminin,
cultured in an incubator at 37°C and used within 24 hours. Details are available (see
Supplemental Data).
Electroporation of dissociated adult DRG neurons with Mrgpr-expression constructs was
carried out using Mouse Neuron Nucleofector Kit (Amaxa Biosystems) following the
manufacturer’s instructions. Electroporated neurons were plated and cultured as described
above.
Calcium imaging
Neurons or HEK293 cells were loaded with fura 2-acetomethoxy ester (Molecular Probes) for
30 min in the dark at room temperature or 45 min at 37°C, respectively. After washing, cells
were imaged at 340 and 380 nm excitation to detect intracellular free calcium. Calcium imaging
assays were performed with an experimenter blind to genotype. Each experiment was done at
least three times and at least 100 cells (neurons or HEK293 cells) were analyzed each time.
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RNA interference
MrgprA3 and MrgprC11 on-target siRNAs were purchased from Thermo Scientific. 0.175
nmol MrgprA3 or MrgprC11 siRNA was electroporated into WT DRG neurons, respectively.
After three days culture, neurons were re-plated on glass coverslips for calcium imaging.
HEK293 cells in 12-well plate were co-transfected with 2 µg Mrgpr-expression constructs and
2 µg siRNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol.
After one day culture, cells were lysated for western blot.
Whole-cell current-clamp recordings of cultured DRG neurons
Neurons plated on cover slips were transferred into a chamber with the extracellular solution.
Patch pipettes had resistances of 2–4 MΩ. In current clamp recordings, action potential
measurements were performed with an Axon 700B amplifier and the pCLAMP 9.2 software
package (Axon Instruments). Neurons were perfused with 1 mM CQ for 20 sec. All
experiments were performed at room temperature (~25°C). Details are available in the
Supplemental Data.
In situ hybridization and immunostaining
In situ hybridization was performed as previously described (Dong et al., 2001). For MrgprA3
and GRP double staining, after in situ hybridization for MrgprA3, DRG sections were
incubated overnight at 4°C with Rabbit anti-GRP antibody (Immunostar, 1:1000) in PBS/1%
donkey serum/0.3% Triton X-100. After washing twice in PBS, sections were incubated with
biotinylated secondary antibody (Jackson, 1:200) for 2 hours at RT and then washed twice in
PBS and incubated with ABC mix (Elite ABC kit, Vectastain) in PBS at RT for 1 hour. Sections
were washed twice in PBS and incubated with 3,3'-Diaminobenzidine/H2O2 in PBS for color
development.
Single cell RT-PCR
Plated neurons with CQ responsiveness established by calcium imaging were individually
harvested into a glass pipette and transferred into PCR tube. Reverse transcription was done
by Super-Script III CellsDirect (Invitrogen) as previously described (Kwong et al., 2008).
Details for PCR conditions are available in the Supplemental Data.
Data analysis
Data are presented as mean ± standard error of mean (S.E.M). Statistical comparisons were
made using unpaired Student’s t-test and differences were considered significant at p < 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Targeted deletion of a cluster of Mrgpr genes. (A) Top horizontal line represents Mrgpr gene
cluster on WT mouse chromosome 7. The distance between MrgprA1 and MrgprB4 is 845
kilobases, which contains 12 intact Mrgprs (each represented by a black bar with its name on
top). Targeting constructs containing loxP sites (black triangles) and the selection marker genes
were introduced to the MrgprA1 and MrgprB4 loci in ES cells by two rounds (1st and 2nd) of
electroporation and homologous recombination. Positive ES clones with correct targeting in
the two loci underwent a third round of electroporation with CMV-Cre construct. Cre-mediated
recombination resulted in deletion of an Mrgpr cluster between loxP sites. The deletion event
in ES cells (lane 1 and 2; lane 3 as negative control using WT ES cells) was detected by PCR
amplification using primers 1 and 2 flanking the cluster (shown as arrowheads). The PCR
product (456 bp) was further confirmed by sequencing. (B) Southern blot of genomic DNA
with an MrgprA or MrgprC probe. The genomic DNA was digested with BglII. Due to cross-
hybridization, a single MrgprC or MrgprA probe can label multiple members of the MrgprC
or MrgprA subfamily in WT (+/+) and cluster heterozygous mice (+/−) DNA. In homozygous
mice (−/−), most of the positive bands are absent (arrows). (C) The deletion of Mrgpr genes
does not affect cell fate determination of small-diameter sensory neurons. The proportion of
nonpeptidergic (IB4+) and peptidergic (CGRP+) small-diameter sensory neurons does not
differ between WT and Mrgpr-clusterΔ−/− mice (n = 3).
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Figure 2.
Mrgpr-clusterΔ−/− mice show severe deficiency in CQ-induced itch. (A–D) Mrgpr-
clusterΔ−/− mice respond normally to noxious acute thermal stimuli. Response latencies in tail
immersion (50°C, n = 12 per genotype, A), hot plate (50°C, n = 11 per genotype, B), Hargreaves
(n = 24 per genotype, C) and cold plate (0 °C, WT n = 13, KO n = 9, D) tests did not differ
between WT and Mrgpr-clusterΔ−/− mice. (E) The paw withdrawal threshold of Mrgpr-
clusterΔ−/− mice to punctate mechanical stimuli (Von Frey) was comparable to that of WT
mice (n = 12 per genotype). (F) Mrgpr-clusterΔ−/− mice responded normally to noxious acute
chemical stimuli. The writhing responses to intraperitoneal injection of acetic acid (0.6%, 15
ml/kg) were indistinguishable between WT and Mrgpr-clusterΔ−/− mice (n = 12 per genotype).
(G and H) Mrgpr-clusterΔ−/− mice displayed normal histamine-dependent itch. The total
scratching bouts were not significantly different between WT and Mrgpr-clusterΔ−/− mice
during the first 30 min after subcutaneous injection of histamine (10 µmol; WT n = 7, KO n =
10, G) or compound 48/80 (100 µg/50 µl; WT n = 8, KO n = 7, H). (I) Mrgpr-clusterΔ−/−
mice showed deficiency in CQ-induced itch. The total scratching bouts during the first 30 min
after CQ injection (200 µg/50 µl, 8 mM) were significantly decreased in Mrgpr-clusterΔ−/−
mice (n = 9) than in WT littermates (n = 8). The time course shows bouts of scratching at 5
min intervals. (J) Quinoline (QN) failed to induce itch in both WT and Mrgpr-clusterΔ−/−
mice. However, subsequent injection of CQ induced a strong scratch response in WT and a
much weaker response in Mrgpr-clusterΔ−/− mice (n = 5 per genotype). (K) SASH mice
showed a mild but significant reduction in CQ-induced itch compared with WT mice (SASH
n = 8, WT n = 7). (L) SASH mice released significantly less histamine than WT mice after IgE
stimulation of the skin (n = 5 per genotype), which provides strong evidence for the mast cell
deficiency in SASH mice. The data are presented as mean ± SEM. *, P<0.05; **, P<0.01; ***,
P<0.005; two-tailed unpaired t-test or two-way ANOVA.
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Figure 3.
The response of DRG neurons to CQ is Mrgpr-dependent. (A) The response to histamine was
not impaired in Mrgpr-deficient DRG neurons. Calcium imaging showed that the percentage
of Mrgpr-clusterΔ−/− DRG neurons responding to histamine (50 µM) was similar to that of
WT neurons (n = 3 per genotype). (B) ~4.4% of WT DRG neurons responded to CQ (1 mM)
with increased [Ca2+]i whereas Mrgpr-clusterΔ−/− DRG neurons failed to respond to the drug
(n = 3 per genotype). (C–D) Extracellular calcium was required for the CQ-induced [Ca2+]i
increase in DRG neurons. (C) shows representative traces from 3 different DRG neurons in
calcium imaging assays. (D) The CQ-induced increase in [Ca2+]i was almost completely
blocked with EGTA treatment. Ruthenium red (RR) also significantly attenuated [Ca2+]i
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increase evoked by CQ. As a control, sequential treatment of CQ only caused a ~20% reduction
in [Ca2+]i increase. (E) CQ (1 mM) induced APs in DRG neurons. In WT DRG neurons, all
CQ-sensitive neurons (as determined by calcium imaging, n=5) elicited a train of APs evoked
by subsequent CQ treatment. In contrast, none of the neurons tested (n=11) from Mrgpr-
clusterΔ−/− mice showed any response to the drug.
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Figure 4.
Mouse MrgprA3 and human MrgprX1 are the predominant receptors for CQ. HEK293 cells
were transfected with expression constructs for Mrgprs and histamine H1 receptor. The effects
of different agonists on these transfected cells were tested via calcium imaging. Each figure
shows a typical response from three different cells. (A) Fewer than half of MrgprA1-tranfected
cells responded to CQ (1 mM) with increased [Ca2+]i whereas all transfected cells responded
to FMRF (2 µM). (B) All MrgprA3-expressing cells responded to CQ but not histamine. (C)
MrgprA4-expressing cells respond to NPFF (2 µM) but not CQ. (D) MrgprC11-expressing
cells failed to respond to CQ whereas they responded to BAM8-22 (2 µM). (E) Human
MrgprX1 responded to both CQ and BAM8-22 (2 µM). (F) Cells expressing the histamine H1
receptor exhibited a strong response to histamine (50 µM) but failed to respond to CQ.
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Figure 5.
Mrgprs are selectively activated by CQ. (A) Molecules with structures related to CQ. Dose-
response curves for MrgprA3 (B), MrgprA1 (C), and MrgprX1 (D) expressed in HEK 293
cells to the molecules in (A). Each data point represents the mean ± SEM of at least three
independent experiments and at least 50 GFP+ cells were analyzed each time. Calcium
responses at each ligand concentration were normalized to the maximal response subsequently
elicited.
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Figure 6.
MrgprA3 is required for CQ responsiveness in mouse DRG neurons. (A) Fluorescent in situ
hybridization of DRG sections with MrgprA3 (green, arrowheads) and MrgprD (red). The
white dashed line outlines the DRG. (B) RT-PCR analysis of 14 mouse tissues or cell types
for expression of MrgprA3. The only tissues containing MrgprA3 are WT DRG and nodose
ganglia. Notably no band was found in Mrgpr-clusterΔ−/− DRG, confirming MrgprA3 was
deleted in Mrgpr-clusterΔ−/− mice. (C) Single cell RT-PCR was performed on individual DRG
neurons with the responsiveness to CQ (1 mM) established by calcium imaging (shown here
are 12 representative neurons). MrgprA3 mRNA was detected in 8/9 CQ-responsive neurons
(+), but was not detected in any of 11 CQ-unresponsive neurons (−). For a negative control,
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sample of bath solution was used (Bath); Diluted total DRG cDNA was used as positive control
(DRG). Arrows indicate predicted product size for MrgprA3 (150 bp) and β-actin (302 bp).
No product was detected in RT- controls from MrgprA3-expressing cells (n=8). (D) and (E)
show representative traces from 3 different WT DRG neurons electroporated with siRNAs in
calcium imaging assays. (D) CQ-induced increase in [Ca2+]i was completely lost in WT
neurons electroporated with MrgprA3 siRNA. However, these neurons (normally express both
MrgprA3 and MrgprC11) are still sensitive to BAM8-22 (BAM). 24 BAM8-22 sensitive
neurons were analyzed. (E) As a control, CQ responsiveness in WT neurons electroporated
with MrgprC11 siRNA remained intact (10 CQ sensitive neurons analyzed). But MrgprC11
siRNA completely abolished BAM8-22 sensitivity. (F) The efficiency and specificity of
MrgprA3 siRNA were tested by co-transfecting HEK293 cells with MrgprA3 siRNA and
expression constructs of MrgprA3 or MrgprC11. Western blot shows that MrgprA3 siRNA
specifically knocked-down the expression of MrgprA3, but not MrgprC11. (G–M) Mrgpr A3
and MrgprX1 selectively rescued CQ responsiveness in Mrgpr-clusterΔ−/− DRG neurons.
(G) Visualization of Mrgpr-clusterΔ−/− DRG neurons that express MrgprA3-GFP protein.
Note the membrane and axon localization (arrowheads) of MrgprA3-GFP in DRG neurons.
(H) All Mrgpr-clusterΔ−/− neurons electroporated with MrgprA3 fired a train of APs upon
CQ treatment (n=6). (I) Fewer than half of MrgprA1-electroporated neurons (3 out of 7) elicited
a few APs upon CQ treatment. (J) Most Mrgpr-clusterΔ−/− neurons electroporated with
MrgprX1 (5 out of 7 GFP-positive neurons recorded) also generated a train of APs in response
to CQ. (K–M) Each figure shows typical calcium traces from three different neurons. (K) All
MrgprA3-expressing Mrgpr-clusterΔ−/− neurons showed increased [Ca2+]i in response to CQ
(1 mM) but not BAM8-22 (2 µM). (L) All MrgprA1-electroporated mutant neurons showed a
strong response to FMRF (2 µM) whereas only a small portion responded to CQ. (M)
Electroporation of MrgprX1 rendered Mrgpr-clusterΔ−/− DRG neurons sensitivity to both CQ
and BAM8-22.
Liu et al. Page 21
Cell. Author manuscript; available in PMC 2010 November 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7.
CQ-responsiveness defines a specific subpopulation of DRG neurons. (A) CQ-responsive
neurons represented a small population of DRG neurons that also responded to histamine (50
µM) and capsaicin (1 µM) with increased [Ca2+]i monitored by calcium imaging. (B) The total
scratching bouts during the first 30 min after BAM8-22 intradermal injection (50 µI of 1 mM).
WT mice exhibited significantly stronger scratching responses after injection than Mrgpr-
clusterΔ−/− littermates did (n=8 per genotype; * p<0.05). (C) As determined by calcium
imaging, 3.6% of WT DRG neurons responded to BAM8-22 (2 µM) with increased [Ca2+]i
and all of them are also CQ-sensitive (D), whereas Mrgpr-clusterΔ−/− DRG neurons failed to
respond to the drug (n=3 per genotype) (C). (E) The Venn diagram illustrates the relationships
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of histamine- (His), capsaicin- (Cap), chloroquine- (CQ), and BAM8-22- (BAM) responsive
neurons in adult DRG. The sizes of the circles are proportional to the sizes of the cell
populations. (F) WT adult DRG sections were doubly stained by in situ hybridization for
MrgprA3 (blue) and immunostaining using anti-GRP antibody (brown). Most MrgprA3+ cells
(51 out of 55) express GRP. Arrowheads indicate MrgprA3/GRP co-expressing neurons.
Arrows indicate MrgprA3+/GRP− cells.
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